Literature DB >> 27007996

Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data.

Hae-Young Park, Hyun-Nam Ryu, Mi Kyong Shim, Hyun Soon Sohn, Jin-Won Kwon.   

Abstract

OBJECTIVE: This study was conducted to analyze and compare the exposure to individually prescribed drugs and the prevalence of polypharmacy according to age group and concomitant disease in South Korea.
METHODS: The use of prescribed drugs was evaluated according to average numbers of prescription drugs used daily during a year or month, using the Korean Health Insurance Claims Database, which is representative of over 90% of citizens, in 2010 and 2011. The use of prescribed drugs was also analyzed according to concomitant diseases and age. Polypharmacy was defined as the use of 5 or more drugs daily during a specific observation period, and proportions of polypharmacy users were calculated according to comorbidity and age group.
RESULTS: The annual average numbers of daily used prescription drugs in 2010 and 2011 were 0.3 (SD = 0.5), 0.4 (SD = 0.7), 1.2 (SD = 1.5), and 2.3 (SD = 2.0) for people aged < 20 years, 20-49 years, 50-64 years, and ≥ 65 years, respectively. Proportions of individuals demonstrating polypharmacy increased with age and were 9.5% and 44.1% for elderly individuals in the year- and month-based analyses, respectively. The annual average number of daily medications used increased by ~2 drugs in the concomitant disease group, and the higher mortality group used a higher number of prescribed drugs than the lower mortality group.
CONCLUSIONS: The results highlight the elevated burden of multi-medication in elderly patients, and the study found that prescribed drug use increased with age and the number of concomitant diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27007996     DOI: 10.5414/CP202484

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  10 in total

1.  Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.

Authors:  Soojung Hong; Ju Hyun Lee; Eun Kyeong Chun; Kwang-Il Kim; Jin Won Kim; Se Hyun Kim; Yun-Gyoo Lee; In Gyu Hwang; Jin Young Kim; Su-Jin Koh; Yoon Ho Ko; Seong Hoon Shin; In Sook Woo; Tae-Yong Kim; Ji Yeon Baek; Hyun Jung Kim; Hyo Jung Kim; Myung Ah Lee; Jung Hye Kwon; Yong Sang Hong; Hun-Mo Ryoo; Jee Hyun Kim
Journal:  Oncologist       Date:  2019-11-27

2.  Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.

Authors:  Soojung Hong; Ju Hyun Lee; Eun Kyeong Chun; Kwang-Il Kim; Jin Won Kim; Se Hyun Kim; Yun-Gyoo Lee; In Gyu Hwang; Jin Young Kim; Su-Jin Koh; Yoon Ho Ko; Seong Hoon Shin; In Sook Woo; Tae-Yong Kim; Ji Yeon Baek; Hyun Jung Kim; Hyo Jung Kim; Myung Ah Lee; Jung Hye Kwon; Yong Sang Hong; Hun-Mo Ryoo; Jee Hyun Kim
Journal:  Oncologist       Date:  2019-11-27

3.  Healthcare utilization among North Korean refugees in South Korea: a mixed methods study.

Authors:  H R Han; J E Lee; K Kim; Y Chung; M T Kim; C Robinson; M Lee
Journal:  Public Health       Date:  2016-09-02       Impact factor: 2.427

4.  Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them-A multicenter descriptive study according to medication reviews in Hungarian community pharmacies.

Authors:  András Szilvay; Orsolya Somogyi; Annamária Dobszay; Attiláné Meskó; Romána Zelkó; Balázs Hankó
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

5.  The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.

Authors:  Hae-Young Park; Ji-Won Park; Hong Ji Song; Hyun Soon Sohn; Jin-Won Kwon
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

6.  Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy.

Authors:  Esra Yazici; Ali S Cilli; Ahmet B Yazici; Hayriye Baysan; Mustafa Ince; Sukriye Bosgelmez; Serkan Bilgic; Betul Aslan; Atila Erol
Journal:  Clin Pract Epidemiol Ment Health       Date:  2017-08-11

7.  Prescribing patterns of polypharmacy in Korean pediatric patients.

Authors:  Soo-Min Jeon; Susan Park; Sandy Jeong Rhie; Jin-Won Kwon
Journal:  PLoS One       Date:  2019-10-01       Impact factor: 3.240

8.  A Study on the Perceptions of Korean Older Adult Patients and Caregivers about Polypharmacy and Deprescribing.

Authors:  Han-Gyul Lee; Seungwon Kwon; Bo-Hyoung Jang; Jin Pyeong Jeon; Ye-Seul Lee; Woo-Sang Jung; Sang-Kwan Moon; Ki-Ho Cho
Journal:  Int J Environ Res Public Health       Date:  2022-09-11       Impact factor: 4.614

9.  Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study.

Authors:  Tae Ik Chang; Haeyong Park; Dong Wook Kim; Eun Kyung Jeon; Connie M Rhee; Kamyar Kalantar-Zadeh; Ea Wha Kang; Shin-Wook Kang; Seung Hyeok Han
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

10.  Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls.

Authors:  Manon J M van Oosten; Susan J J Logtenberg; Marc H Hemmelder; Martijn J H Leegte; Henk J G Bilo; Kitty J Jager; Vianda S Stel
Journal:  Clin Kidney J       Date:  2021-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.